Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices
about
Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 ExpressionThe feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation.Efforts towards erasing borders in gynecologic cancer?Optical techniques for cervical neoplasia detection.Cytology-Based Screening During Antenatal Care as a Method for Preventing Cervical CancerInitial results of population based cervical cancer screening program using HPV testing in one million Turkish women.Use of Mueller matrix polarimetry and optical coherence tomography in the characterization of cervical collagen anisotropy.Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China.Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review.Retinoic acid receptor beta promoter methylation and risk of cervical cancer.Potential new biomarkers for squamous carcinoma of the uterine cervix.Th17 response in patients with cervical cancer
P2860
Q30491531-A2CB1921-EFAD-4856-866A-DE6BA09E9675Q33685995-612BFD77-FD37-49B8-961A-367E81EE6DF6Q33911718-F6B1EA88-BC95-4C3E-86A9-093632355BA8Q36162825-0E8BF74E-0E96-4A42-9065-EB4A69C5FC31Q39442569-09B12518-558E-48D4-B04D-92AD9AF3A4A5Q42351204-54981964-1F02-4D7E-816F-05165934E9E1Q42371103-1D620C34-2BC1-40B4-A517-24DC8A053B37Q47125334-89741757-308D-4319-8D65-97235503EF82Q47319540-7A0C2B26-E917-40A6-A5E4-D60657460D18Q47739908-73D4928D-B189-4ACA-B2AB-FC2B9F6E67A0Q48529794-DE191303-16BA-4288-9544-662C20B49697Q49454383-DD257D74-07AB-43AC-B17C-23F384D78FDFQ54269009-CB903F8A-262B-4864-B53B-16A6C4B9F8EDQ55715397-17106E57-B0E8-4B62-8FEC-EEBFCBD1BCB4Q58572928-C1C052C0-E1CF-4435-9224-056787B1F15E
P2860
Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cervical cancer screening in d ...... echnologies and policy choices
@ast
Cervical cancer screening in d ...... echnologies and policy choices
@en
Cervical cancer screening in d ...... echnologies and policy choices
@nl
type
label
Cervical cancer screening in d ...... echnologies and policy choices
@ast
Cervical cancer screening in d ...... echnologies and policy choices
@en
Cervical cancer screening in d ...... echnologies and policy choices
@nl
prefLabel
Cervical cancer screening in d ...... echnologies and policy choices
@ast
Cervical cancer screening in d ...... echnologies and policy choices
@en
Cervical cancer screening in d ...... echnologies and policy choices
@nl
P2093
P2860
P3181
P356
P1476
Cervical cancer screening in d ...... echnologies and policy choices
@en
P2093
Gabriel Dongui
Patrick Petignat
Pierre Vassilakos
Rosa Catarino
P2860
P304
P3181
P356
10.5306/WJCO.V6.I6.281
P407
P577
2015-12-10T00:00:00Z